106 related articles for article (PubMed ID: 18830930)
21. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer.
Boussioutas A; Li H; Liu J; Waring P; Lade S; Holloway AJ; Taupin D; Gorringe K; Haviv I; Desmond PV; Bowtell DD
Cancer Res; 2003 May; 63(10):2569-77. PubMed ID: 12750281
[TBL] [Abstract][Full Text] [Related]
22. A study of Smad4 and Smad7 expression in surgically resected samples of gastric adenocarcinoma and their correlation with clinicopathological parameters and patient survival.
Zizi-Sermpetzoglou A; Myoteri D; Arkoumani E; Voultsos M; Marinis A
J BUON; 2014; 19(1):221-7. PubMed ID: 24659668
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of TGF beta (TGF-β), TGF beta receptor 1 (TGFBR1), and Ki67 in intestinal variant of gastric adenocarcinomas.
Docea AO; Mitruţ P; Grigore D; Pirici D; Călina DC; Gofiţă E
Rom J Morphol Embryol; 2012; 53(3 Suppl):683-92. PubMed ID: 23188426
[TBL] [Abstract][Full Text] [Related]
24. Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion.
Agoston AT; Odze RD
Hum Pathol; 2014 Mar; 45(3):446-55. PubMed ID: 24529328
[TBL] [Abstract][Full Text] [Related]
25. Expression of tumor suppressor and tumor-related proteins in differentiated carcinoma, undifferentiated carcinoma with tubular component and pure undifferentiated carcinoma of the stomach.
Honda T; Tamura G; Endoh Y; Nishizuka S; Kawata S; Motoyama T
Jpn J Clin Oncol; 2005 Oct; 35(10):580-6. PubMed ID: 16254038
[TBL] [Abstract][Full Text] [Related]
26. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
27. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
[TBL] [Abstract][Full Text] [Related]
28. [Point mutation of TP53 suppressor gene in pre-neoplastic and neoplastic lesions of the stomach].
Araya JC; Roa JC; Villaseca MA; Roa I; Guzmán P; Alvarado C; Melo A
Rev Med Chil; 2003 Apr; 131(4):359-65. PubMed ID: 12870229
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype.
Ohmura K; Tamura G; Endoh Y; Sakata K; Takahashi T; Motoyama T
Hum Pathol; 2000 Sep; 31(9):1031-5. PubMed ID: 11014567
[TBL] [Abstract][Full Text] [Related]
30. Bax and Bcl-2 protein expression in gastric precancerous lesions: immunohistochemical study.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Sakorafas G; Pavlakis G; Arvanitidis D; Tsianos E; Agnantis NJ
J Gastroenterol Hepatol; 2005 Nov; 20(11):1674-8. PubMed ID: 16246184
[TBL] [Abstract][Full Text] [Related]
31. The evaluation of SOX9 expression and its relationship with carcinoembryonic antigen-related cell adhesion molecule 1 in gastric neoplastic and nonneoplastic lesions.
Liu JN; Shang Guan YM; Qi YZ; Wang HB; Zhang TG; Zhou CJ
Ann Diagn Pathol; 2012 Aug; 16(4):235-44. PubMed ID: 22209504
[TBL] [Abstract][Full Text] [Related]
32. [The prognostic significance of expression of c-met oncogene and its relation to gastric mucosal lesions].
Zhuang X; Zheng J; Lin S; Sun G; Li Y
Zhonghua Bing Li Xue Za Zhi; 2000 Dec; 29(6):409-11. PubMed ID: 11866940
[TBL] [Abstract][Full Text] [Related]
33. Expression and significance of TWIST basic helix-loop-helix protein over-expression in gastric cancer.
Yan-Qi Z; Xue-Yan G; Shuang H; Yu C; Fu-Lin G; Fei-Hu B; Shi-Ren S; Xu-Feng W; Jie D; Dai-Ming F
Pathology; 2007 Oct; 39(5):470-5. PubMed ID: 17886095
[TBL] [Abstract][Full Text] [Related]
34. Chronology of p53 protein accumulation in gastric carcinogenesis.
Craanen ME; Blok P; Dekker W; Offerhaus GJ; Tytgat GN
Gut; 1995 Jun; 36(6):848-52. PubMed ID: 7615272
[TBL] [Abstract][Full Text] [Related]
35. Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous?
Nakayama T; Ling ZQ; Mukaisho K; Hattori T; Sugihara H
BMC Cancer; 2010 Jun; 10():311. PubMed ID: 20565940
[TBL] [Abstract][Full Text] [Related]
36. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium.
Ho SB; Shekels LL; Toribara NW; Kim YS; Lyftogt C; Cherwitz DL; Niehans GA
Cancer Res; 1995 Jun; 55(12):2681-90. PubMed ID: 7780985
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
Landis MD; Seachrist DD; Montañez-Wiscovich ME; Danielpour D; Keri RA
Oncogene; 2005 Aug; 24(33):5173-90. PubMed ID: 15897883
[TBL] [Abstract][Full Text] [Related]
38. Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia.
Rokutan H; Abe H; Nakamura H; Ushiku T; Arakawa E; Hosoda F; Yachida S; Tsuji Y; Fujishiro M; Koike K; Totoki Y; Fukayama M; Shibata T
J Pathol; 2019 Apr; 247(4):494-504. PubMed ID: 30474112
[TBL] [Abstract][Full Text] [Related]
39. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
40. p53 alteration in gastric precancerous lesions.
Shiao YH; Rugge M; Correa P; Lehmann HP; Scheer WD
Am J Pathol; 1994 Mar; 144(3):511-7. PubMed ID: 8129036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
